We Help Companies in any Sector Make More of What They Have. 

Pharmaceutical Insights

BUSINESS PROBLEM

Keep up with the latest developments in a given disease area, or zoom into news on a specific company.

Link news data to customers, investments or potential investors can prove challenging.

Find out who is respected and seen as a thought/opinion leader in your industry.

 

Unlock marketing, trend analysis and keep up-to-date on specific events in your relevant disease areas. 

KNIGHTS SOLUTION

Whether it's new acquisitions, trials or research we collect and disambiguate so you can browse our curated data and rapidly get answers to your questions.

Our fully fledged KOL (Key Opinion Leader) solution combines many sources of information using our advanced entity resolution engine to create a network of individuals. We then apply machine learning models to transform the data and measure their impact on your focus disease area.

 
Banking Customer Insights

BUSINESS PROBLEM

A company wants to be able to see a holistic view of their customers or employees to better understand who they are and how they have interacted historically with their business.

KNIGHTS SOLUTION

Using our entity resolution engine we can knit together data from multiple internal and external data sources finding connections which a customer ID may not necessarily capture.


This allows for an enriched understanding of individuals interacting with the organisation.


It enables a company to monitor their customer base and is the foundation upon which to build compliance or marketing models.

 
Water
Industry Insights

COMPANY KNOWLEDGE GRAPH

​Helps with:

  • KYC and AML compliance

  • Fraud detection

  • Churn prediction

  • Personalised marketing

  • Cyber Security and Device Monitoring


KEY OPINION LEADERS

Find people like:

  • Key Researchers

  • Key Clinicians

  • Governmental and Policy Makers

  • Digital Influencers

  • Key thought leaders and speakers


MONITORING EVENTS

Keep up to date with:

  • Key industry developments

  • Investments

  • Mergers or Acquisitions

  • New products

  • Results from Clinical Trials

  • Collaborations